The FDA's refusal to review the biologics license application (BLA) indicates significant deficiencies in the submission. This will cause major delays to market entry, increase R&D costs to remediate the application, and puts future revenue from the flu vaccine program at risk.
Filing excerpt
On February 3, 2026, the FDA's Center for Biologics Evaluation and Research (“CBER”) notified the Company that it will not initiate a review of the biologics license application (“BLA”) for the Company's investigational influenza vaccine, mRNA-1010, and has issued a Refusal-to-File letter.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-8kcomplianceBurdenGet every 8-K signal for Moderna and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Moderna this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/fda00c6b-62a3-4988-b3c7-ca0c461a7c27 returns this record as JSON. POST /v1/companies/enrich returns every signal for modernatx.com.
{
"signal_id": "fda00c6b-62a3-4988-b3c7-ca0c461a7c27",
"signal_type": "sec-8k",
"signal_subtype": "complianceBurden",
"detected_at": "2026-02-17T09:03:45.262+00:00",
"company": {
"name": "Moderna",
"domain": "modernatx.com"
},
"data": {
"detail": "The FDA's refusal to review the biologics license application (BLA) indicates significant deficiencies in the submission. This will cause major delays to market entry, increase R&D costs to remediate the application, and puts future revenue from the flu vaccine program at risk.",
"metrics": {
"timeframe": "immediate"
},
"summary": "Moderna receives FDA Refusal-to-File letter for its mRNA-1010 influenza vaccine.",
"excerpts": "On February 3, 2026, the FDA's Center for Biologics Evaluation and Research (“CBER”) notified the Company that it will not initiate a review of the biologics license application (“BLA”) for the Company's investigational influenza vaccine, mRNA-1010, and has issued a Refusal-to-File letter.",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285226000012/mrna-20260203.htm",
"filing_date": "2026-02-10",
"filing_year": 2026,
"fiscal_year_end": "02/03",
"sales_relevance": "GRC tools needed",
"signal_category": "risk",
"regions_mentioned": [
"North America"
]
}
}
curl https://signals.autobound.ai/v1/signals/fda00c6b-62a3-4988-b3c7-ca0c461a7c27 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"modernatx.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.